Acute Iliofemoral DVT

More documents

Recommendations

Info

ACCP Guidelines: Initial DVT Therapy 1.1.3 In patients with acute DVT, we recommend initial treatment with LMWH, UFH, or fondaparinux for at least 5 days and until the INR is ≥ 2.0 for 24 h (Grade 1C). 1.4.1 In patients with acute DVT, we recommend initial treatment with LMWH SC once or twice daily, as an outpatient if possible (Grade 1C), or as an inpatient if necessary (Grade 1A), rather than treatment with UFH. Kearon, et al., Chest, 2008; 133: 454S-545S.
ACCP Guidelines: Warfarin Therapy 1.1.4 In patients with acute DVT, we recommend initiation of VKA together with LMWH, UFH, or fondaparinux on the first treatment day rather than delayed initiation of VKA (Grade 1A). 2.2.1 In patients with DVT, we recommend that the dose of VKA be adjusted to maintain a target INR of 2.5 (range, 2.0-3.0) for all treatment durations (Grade 1A). Kearon, et al., Chest, 2008; 133: 454S-545S.
Page 1 and 2: Medical Management of Acute Iliofem
Page 3 and 4: Great Debates
Page 9 and 10: Audience Response
Page 11 and 12: Anticoagulation vs. No Anticoagulat
Page 13: ACCP Guidelines: Initial DVT Therap
Page 17 and 18: Poor Management of Warfarin and Rec
Page 21 and 22: New Anticoagulants: Dabigatran •
Page 23 and 24: Limitations of the New Anticoagulan
Page 25 and 26: Iliofemoral DVT • Patients with i
Page 27 and 28: Post-thrombotic Syndrome • Proxim
Page 29 and 30: Compression Stockings and PTS • 1
Page 31 and 32: Systemic Thrombolytic Therapy Varia
Page 35 and 36: CaVenT Study: Efficacy Catheter-dir
Page 37 and 38: ACCP Guidelines 1.9.1 In selected p
Page 39: Conclusions • Anticoagulant thera

Acute Iliofemoral DVT

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?